PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Gesamtlänge aller Episoden: 1 day 21 hours 21 minutes
Stroke Prevention, Type 2 Diabetes, and GLP-1 Receptor Agonists: What Neurologists Need to Know
Stroke Prevention, Type 2 Diabetes, and GLP-1 Receptor Agonists: What Neurologists Need to Know
Modern Management of Chronic Kidney Disease: A Look to the Future
Modern Management of Chronic Kidney Disease: A Look to the Future
SGLT2 Inhibition for HF: Evidence From Virtual Scientific Sessions 2020
SGLT2 Inhibition for HF: Evidence From Virtual Scientific Sessions 2020
Evaluating the Evidence for SGLT2 Inhibition in CKD: Highlights of Kidney Week 2020
Evaluating the Evidence for SGLT2 Inhibition in CKD: Highlights of Kidney Week 2020
Novel Strategies for Chronic Kidney Disease: New Data, New Paradigm?
Novel Strategies for Chronic Kidney Disease: New Data, New Paradigm?
Modern Management of Chronic Kidney Disease: A Look to the Future
Modern Management of Chronic Kidney Disease: A Look to the Future
Breaking the Cycle of Severe Hypoglycemia in Diabetes: Educating Clinicians and Patients Alike
Breaking the Cycle of Severe Hypoglycemia in Diabetes: Educating Clinicians and Patients Alike
New Targets in Heart Failure: Congress Updates on SGLT2 Inhibitors
New Targets in Heart Failure: Congress Updates on SGLT2 Inhibitors
Evaluating the Evidence for SGLT2 Inhibition in CKD
Evaluating the Evidence for SGLT2 Inhibition in CKD